compound, pharmaceutical composition, methods for inhibiting poly (adp-ribose) polymerase in a patient, for treating a disease, use of a compound, and article of manufacture.
The invention provides a compound of the formula: or a pharmaceutically acceptable salt or solvate thereof. Also provided are pharmaceutical compositions comprising the compound or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier, excipient, binder or diluent. The compounds and compositions of the invention are useful for the treatment of cancer.
